Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
Open Access
- 1 April 2021
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 106 (4), 1163-1166
- https://doi.org/10.3324/haematol.2020.246843
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid LeukemiaCell, 2016
- Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amidesProceedings of the National Academy of Sciences of the United States of America, 2016
- AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone MarrowCell Stem Cell, 2015
- Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer CellsChemMedChem, 2015
- Glucose transport machinery reconstituted in cell modelsChemical Communications, 2014
- A distinct glucose metabolism signature of acute myeloid leukemia with prognostic valueBlood, 2014
- Crystal structure of the human glucose transporter GLUT1Nature, 2014
- Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cellsBioorganic & Medicinal Chemistry Letters, 2013
- ATP regulation of the human red cell sugar transporter.Online Journal of Public Health Informatics, 1986
- On Respiratory Impairment in Cancer CellsScience, 1956